The merger between BerGenBio ASA and Oncoinvent ASA was completed 29 October 2025, and the Combined company was renamed to Oncoinvent. This webpage contains historical documents related to BerGenBio before the merger. Oncoinvent ASA Recent news • 27th August 2026 Oncoinvent presents first half 2026 results Read More • 17th August 2026 Invitation to First-Half 2026 webcast – Thursday 27 August 2026 Read More • 11th August 2026 Oncoinvent announces publication of normal tissue dosimetry results in Journal of Nuclear Medicine Read More • 18th June 2026 Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin[®] Read More • 20th May 2026 Oncoinvent ASA: Grant of share options to member of the Board following AGM Read More • 20th May 2026 Oncoinvent ASA: Minutes from Annual General Meeting Read More • 5th May 2026 Oncoinvent ASA: Share capital decrease completed Read More • 29th April 2026 Oncoinvent presents corporate update in live webcast Read More • 28th April 2026 Oncoinvent ASA: Notice of Annual General Meeting Read More All news
